Bank of New York Mellon’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-21,058
| Closed | -$194K | – | 4584 |
|
2021
Q2 | $194K | Sell |
21,058
-109,653
| -84% | -$1.01M | ﹤0.01% | 4104 |
|
2021
Q1 | $650K | Sell |
130,711
-119
| -0.1% | -$592 | ﹤0.01% | 3547 |
|
2020
Q4 | $564K | Sell |
130,830
-7,172
| -5% | -$30.9K | ﹤0.01% | 3561 |
|
2020
Q3 | $592K | Sell |
138,002
-9,972
| -7% | -$42.8K | ﹤0.01% | 3407 |
|
2020
Q2 | $665K | Buy |
147,974
+16,904
| +13% | +$76K | ﹤0.01% | 3323 |
|
2020
Q1 | $525K | Buy |
131,070
+17,323
| +15% | +$69.4K | ﹤0.01% | 3336 |
|
2019
Q4 | $965K | Buy |
113,747
+3,684
| +3% | +$31.3K | ﹤0.01% | 3263 |
|
2019
Q3 | $754K | Sell |
110,063
-2,396
| -2% | -$16.4K | ﹤0.01% | 3322 |
|
2019
Q2 | $936K | Buy |
112,459
+1,545
| +1% | +$12.9K | ﹤0.01% | 3258 |
|
2019
Q1 | $1.02M | Buy |
110,914
+9,545
| +9% | +$87.6K | ﹤0.01% | 3166 |
|
2018
Q4 | $1.11M | Buy |
101,369
+10,522
| +12% | +$115K | ﹤0.01% | 3046 |
|
2018
Q3 | $1.27M | Buy |
90,847
+17,798
| +24% | +$248K | ﹤0.01% | 3120 |
|
2018
Q2 | $778K | Sell |
73,049
-15,114
| -17% | -$161K | ﹤0.01% | 3389 |
|
2018
Q1 | $762K | Buy |
88,163
+4,620
| +6% | +$39.9K | ﹤0.01% | 3347 |
|
2017
Q4 | $789K | Buy |
83,543
+8,995
| +12% | +$85K | ﹤0.01% | 3372 |
|
2017
Q3 | $586K | Buy |
74,548
+11,081
| +17% | +$87.1K | ﹤0.01% | 3509 |
|
2017
Q2 | $546K | Buy |
+63,467
| New | +$546K | ﹤0.01% | 3563 |
|
2015
Q2 | – | Sell |
-39,466
| Closed | -$282K | – | 4290 |
|
2015
Q1 | $282K | Sell |
39,466
-73
| -0.2% | -$522 | ﹤0.01% | 3799 |
|
2014
Q4 | $295K | Sell |
39,539
-716
| -2% | -$5.34K | ﹤0.01% | 3783 |
|
2014
Q3 | $372K | Sell |
40,255
-95
| -0.2% | -$878 | ﹤0.01% | 3713 |
|
2014
Q2 | $753K | Buy |
40,350
+18,413
| +84% | +$344K | ﹤0.01% | 3464 |
|
2014
Q1 | $407K | Buy |
+21,937
| New | +$407K | ﹤0.01% | 3637 |
|